| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8485909 | Vaccine | 2018 | 7 Pages |
Abstract
This analysis suggests that in the UK, the burden of PCV13 disease is greater in adults outside the traditional 'at-risk' groups compared to adults in 'at-risk' groups.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Priya Daniel, Chamira Rodrigo, Thomas Bewick, Carmen Sheppard, Sonia Greenwood, Tricia M. McKeever, Caroline Trotter, Wei Shen Lim,